Q1 2014 IPO Flood Continues, Most Active Since 2006
Q1 2014 was again the most active for IPOs in years. Biotech heavy trend continues. The average IPO returns however, dropped to 25% from 2013's lofty 46% - poor follow through was notable.
NEW YORK - April 25, 2014 - PRLog -- Continuing the theme of 2013, the first quarter of 2014 saw an influx of IPOs that made it the most active IPO market since 2000. There were a total of 64 companies that came public in the first quarter raising a total of 10.6 billion dollars. Out of the 64 deals that priced, 26 were biotechs which again shows a continuing theme from 2013. The average IPO return was 25%, a significant drop from the 46% in the fourth quarter of 2013.
The biggest standout for the first quarter of 2014 was the lack of follow through on the deals after the opening. Most of this occurred in the technology sector. Castlight Health which opened up 134% is currently down 53%; Paylocity Holdings opened up 82% is currently down 36.13%; and Coupons.com Inc. opened up 69% and is currently down 25%.
For complete details, charts and history, the current IPO querterly report is always available at Triad Securities
Triad also maintains a New Issue 90-day Window, with current IPO pricing and performance:
Triad Securities Corp’s customers subscribe to its IPO reporting service, leverage its full service execution desk, and take advantage Triad's prime brokerage services. Triad arranges office space, consulting, and custom services for trading groups and hedge funds.
Triad Securities has not contributed to, written, authorized, sponsored, or endorsed any of the news items, or any of the policies, activities, products, or services offered on the external sites or by any advertiser on the external sites. All news articles are from external and unaffiliated media outlets. All information provided “as is” for informational purposes only, not intended for trading purposes or advice.
Triad Securities Corp. (www.triadsecurities.com)
CONTACT: Brett Markowitz, Vice President Sales, +1-212-349-0871, +1-800-221-8440
Page Updated Last on: Apr 25, 2014